FDAnews
www.fdanews.com/articles/73747-theratechnologies-sells-celmed-investment

THERATECHNOLOGIES SELLS CELMED INVESTMENT

June 27, 2005

Theratechnologies has announced the sale of its 37% investment in Celmed BioSciences (Celmed) for total proceeds of up to $ 8.4 million. The acquirer is a group of minority shareholders of Celmed. The total proceeds of the agreement comprise an upfront cash payment of $2.8 million and future milestone payments related to the success of Celmed's most advanced products. The transaction is cash flow positive for

Theratechnologies. However, a non-cash charge of approximately $ 7 million will be recorded in the second quarter of 2005 as a result of the sale.

Canada NewsWire Group (http://www.newswire.ca/en/releases/archive/June2005/20/c3830.html)